The isoflavone genistein inhibits LPS-stimulated TNFα, but not IL-6 expression in monocytes from hemodialysis patients and healthy subjects

Clinical Nephrology

Volumn 65, Issue 4, 2006, Pages 267-275

  Asmis, R ^a   Stevens, J ^b   Begley, J G ^b   Grimes, B ^b   Van Zant, G ^b   Fanti, P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cardiovascular disease; Cytokine; Inflammation

Indexed keywords

CD14 ANTIGEN; GENISTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INHIBITION KINETICS; KIDNEY FAILURE; MONOCYTE; MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 33645783213     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp65267     Document Type: Article

References (28)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262: 5592-5595.
2. Al Saady NM, Leatham EW, Gupta S, Kwan JT, Eastwood JB, Seymour CA. Monocyte expression of tissue factor and adhesion molecules: The link with accelerated coronary artery disease in patients with chronic renal failure. Heart. 1999; 81: 134-140.
3. Bingisser R, Speich R, Zollinger A, Russi E, Frei K. Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis. Respiration. 2000; 67: 280-286.
4. Cox G. IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol. 1996; 271: L566-L571.
5. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Maynot A, Verger C, Dahmane D, de Groote D, Jungers P. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol. 1995; 154: 882-892.
6. Fanti P, Asmis R, Fraer M, Stephenson TJ, Sawaya BP, Franke AA. Improvement of inflammation and malnutrition correlates with the blood levels of soy isoflavones, following dietary intervention in HD patients. J Am Soc Nephrol. 2004; 15: 170A.
7. Geng Y, Zhang B, Lotz M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol. 1993; 151: 6692-6700.
8. Gunnett CA, Berg DJ, Faraci FH, Feuerstein G. Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke. 1999; 30: 2191-2195.
9. Ho AS, Moore KW. Interleukin-10 and its receptor. Ther Immunol. 1994; 1: 173-185.
10. Huang Y, Cao S, Nagamani M, Anderson KE, Grady JJ, Lu LJ. Decreased circulating levels of tumor necrosis factor-alpha (TNF-{alpha}) in postmenopausal women during consumption of soy containing isoflavones. J Clin Endocrinol Metab. 2005; 3956-3962.
11. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple dD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis. 2003; 42: 864-881.
12. Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol. 2001; 12: 1549-1557.
13. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand-binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997; 138: 863-870.
14. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998; 139: 4252-4263.
15. Leon LR, Kozak W, Kluger MJ. Role of IL-10 in inflammation. Studies using cytokine knockout mice. Ann NY Acad Sci. 1998; 856: 69-75.
16. Ma Q, Kinneer K. Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages. J Biol Chem. 2002; 277: 2477-2484.
17. Makela S, Savolainen H, Aavik E, Myllarniemi M, Strauss L, Taskinen E, Gustafsson JA, Hayry P. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci USA. 1999; 96: 7077-7082.
18. Malaponte G, Bevelacqua V, Fatuzzo P, Rapisarda F, Emmanuele G, Travali S, Mazzarino MC. IL-1beta, TNF-alpha and IL-6 release from monocytes in hemodialysis patients in relation to dialytic age. Nephrol Dial Transplant. 2002; 17: 1964-1970.
19. Mollenhauer HH, Morre DJ, Rowe LD. Alteration of intracellular traffic by monensin, mechanism, specificity and relationship to toxicity. Biochim Biophys Acta. 1990; 1031: 225-246.
20. National Kidney Foundation - Disease Outcome Quality Initiative: Clinical Practice Guidelines for Hemodialysis Adequacy, in K/DOQI Update. New York: National Kidney Foundation; 2000.
21. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res. 2004; 94: 119-126.
22. Pinderski Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, Fyfe AI. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1999; 19: 2847-2853.
23. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55: 1899-1911.
24. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M. IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int. 2005; 67: 1216-1233.
25. van Riemsdijk-van Overbeeke IC, Baan CC, Hesse CJ, Loonen EH, Niesters HG, Zietse R, Weimar W. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure. Clin Nephrol. 2000; 53: 115-123.
26. Verdrengh M, Collins LV, Bergin P, Tarkowski A. Phytoestrogen genistein as an anti-staphylococcal agent. Microbes Infect. 2004; 6: 86-92.
27. Wintergerst ES, Jelk J, Asmis R. Differential expression of CD14, CD36 and the LDL receptor on human monocyte-derived macrophages. A novel cell culture system to study macrophage differentiation and heterogeneity. Histochem Cell Biol. 1998; 110: 231-241.
28. Yao Q, Pecoits-Filho, R, Lindholm B, Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004; 38: 405-416.